Rallybio Corp. (RLYB)
16.64
+0.24
(+1.46%)
USD |
NASDAQ |
Oct 23, 16:00
16.48
-0.16
(-0.96%)
After-Hours: 20:00
Rallybio Market Cap : 88.31M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 88.31M |
| October 22, 2026 | 87.03M |
| October 21, 2026 | 86.08M |
| October 20, 2026 | 86.93M |
| October 19, 2026 | 86.77M |
| October 16, 2026 | 86.40M |
| October 15, 2026 | 89.02M |
| October 14, 2026 | 89.71M |
| October 13, 2026 | 88.73M |
| October 12, 2026 | 89.10M |
| October 09, 2026 | 90.32M |
| October 08, 2026 | 90.16M |
| October 07, 2026 | 89.85M |
| October 06, 2026 | 90.64M |
| October 05, 2026 | 89.69M |
| October 02, 2026 | 90.64M |
| October 01, 2026 | 88.94M |
| September 30, 2026 | 91.28M |
| September 29, 2026 | 91.38M |
| September 28, 2026 | 90.48M |
| September 25, 2026 | 88.20M |
| September 24, 2026 | 88.15M |
| September 23, 2026 | 89.47M |
| September 22, 2026 | 89.79M |
| September 21, 2026 | 89.85M |
| Date | Value |
|---|---|
| September 18, 2026 | 91.23M |
| September 17, 2026 | 91.07M |
| September 16, 2026 | 90.69M |
| September 15, 2026 | 91.38M |
| September 14, 2026 | 87.62M |
| September 11, 2026 | 89.55M |
| September 10, 2026 | 88.89M |
| September 09, 2026 | 90.06M |
| September 08, 2026 | 88.15M |
| September 04, 2026 | 89.82M |
| September 03, 2026 | 89.55M |
| September 02, 2026 | 89.90M |
| September 01, 2026 | 88.57M |
| August 31, 2026 | 89.10M |
| August 28, 2026 | 89.21M |
| August 27, 2026 | 88.94M |
| August 26, 2026 | 89.58M |
| August 25, 2026 | 89.61M |
| August 24, 2026 | 89.16M |
| August 21, 2026 | 89.32M |
| August 20, 2026 | 88.09M |
| August 19, 2026 | 90.22M |
| August 18, 2026 | 89.00M |
| August 17, 2026 | 90.22M |
| August 14, 2026 | 90.16M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.189B |
| Oncolytics Biotech, Inc. | 62.61M |
| Sangamo Therapeutics, Inc. | 47.64M |
| Sarepta Therapeutics, Inc. | 1.873B |
| Anixa Biosciences, Inc. | 103.41M |
Market Cap Related Metrics
| PE Ratio | 2.130 |
| PS Ratio | 144.26 |
| Price to Book Value | 0.9345 |
| Price to Free Cash Flow | 3.489 |
| Price | 16.64 |
| Earnings Yield | 46.95% |
| Normalized PE Ratio | 6.713 |